Neogen (NEOG) Other financing activities (2010 - 2026)
Neogen's (NEOG) quarterly Other financing activities came in at $822000.0 in Q1 2026, down 19.25% year-on-year from $1.0 million in Q1 2025, and up 3144.44% quarter-over-quarter from -$27000.0 in Q4 2025.
Neogen (NEOG) Other financing activities (2010 - 2026) Analysis & Trends
Neogen's Other financing activities history runs 17 years deep, the most recent figure standing at $822000.0 for Q1 2026.
- On a quarterly basis, Other financing activities fell 19.25% year-over-year to $822000.0 in Q1 2026; TTM through Feb 2026 was $1.7 million, a 21.28% decrease from a year earlier, with the FY2025 full-year figure at $2.2 million, down 8.71% from the prior year.
- Other financing activities advanced to $822000.0 in Q1 2026 per NEOG's latest filing, from -$27000.0 in the prior quarter.
- Across five years, Other financing activities topped out at $7.9 million in Q2 2022 and bottomed at -$6.6 million in Q1 2022.
- The 5-year median for Other financing activities is $252000.0 (2023), against an average of $523941.2.
- Across the five-year window, Other financing activities sank 165.26% in 2022 and jumped 5173.91% in 2024, its largest moves.
- Year by year, Other financing activities stood at $15000.0 in 2022, then jumped by 1020.0% to $168000.0 in 2023, then tumbled by 37.5% to $105000.0 in 2024, then plunged by 125.71% to -$27000.0 in 2025, then surged by 3144.44% to $822000.0 in 2026.
- Per Business Quant, the three latest NEOG Other financing activities figures stand at $822000.0 (Q1 2026), -$27000.0 (Q4 2025), and $905000.0 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - |
| 10 | Neogen | 2.09 Bn | 1.93 Bn | 99.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Feb 28, 2026 | 822,000.00 |
| Feb 28, 2026 | 822,000.00 |
| Nov 30, 2025 | -27,000.00 |
| Nov 30, 2025 | -27,000.00 |
| Aug 31, 2025 | 905,000.00 |
| Aug 31, 2025 | 905,000.00 |
| May 31, 2025 | 42,000.00 |
| May 31, 2025 | 42,000.00 |
| Feb 28, 2025 | 1.02 Mn |
| Feb 28, 2025 | 1.02 Mn |
| Nov 30, 2024 | 105,000.00 |
| Nov 30, 2024 | 105,000.00 |
| Aug 31, 2024 | 1.08 Mn |
| Aug 31, 2024 | 1.08 Mn |
| May 31, 2024 | 13,000.00 |
| May 31, 2024 | 13,000.00 |
| Feb 29, 2024 | 1.21 Mn |
| Feb 29, 2024 | 1.21 Mn |
| Nov 30, 2023 | 168,000.00 |
| Nov 30, 2023 | 168,000.00 |